LUV
62
-9
KMI
63
6
ALLE
39
-5
LEN
38
-3
ESS
39
-5
HRL
39
3
GILD
49
-2
BBY
41
-9
CAG
34
-3
TMO
52
-7
A
48
-3
DUK
55
-2
AVGO
26
-2
DGX
39
3
EL
52
-10
ADM
48
-3
KSS
59
-5
ADSK
66
10
AAP
36
-5
FIS
53
-2
LUV
62
-9
KMI
63
6
ALLE
39
-5
LEN
38
-3
ESS
39
-5
HRL
39
3
GILD
49
-2
BBY
41
-9
CAG
34
-3
TMO
52
-7
A
48
-3
DUK
55
-2
AVGO
26
-2
DGX
39
3
EL
52
-10
ADM
48
-3
KSS
59
-5
ADSK
66
10
AAP
36
-5
FIS
53
-2
Financhill
Back

GT Biopharma, Inc. Stock Predictions

Missed $0.81? RAD Intel Now Open at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
9

GTBP
GT Biopharma, Inc.

Last Price:
$0.63
Seasonality Move:
-1.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Still Time to Get In: RAD Intel at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

GT Biopharma, Inc. Stock Forecast

  • Is GT Biopharma, Inc. Stock Undervalued?
    The current GT Biopharma, Inc. [GTBP] share price is $0.63. The Score for GTBP is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • GTBP is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will GT Biopharma, Inc. Stock Go Up Next Year?

Data Unavailable

GT Biopharma, Inc. Stock Rating

Data Unavailable

GT Biopharma, Inc. Stock Price History

Is GTBP stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
gtbiopharma.com

52-Week Data

52-Week High:
4.10
52-Week Low:
0.54

Prediction Charts

Market Cap:
6.7M
Price in USD:
0.63
Volume:
1.6M
Beta:
0.95

Technical Analysis

SMA50:
0.70
SMA100:
1.04
SMA200:
1.77
52-Wk Change:
-77.01%

Stock Predictions

  • Is GT Biopharma, Inc. stock public?
    Yes, GT Biopharma, Inc. is a publicly traded company.
  • What is the GT Biopharma, Inc. stock quote today?
    The GT Biopharma, Inc. stock price is 0.63 USD today.
  • How to buy GT Biopharma, Inc. stock online?
    You can buy GT Biopharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-14 0.74 0.92 1.15 0.71
Nov-17 0.76 0.69 0.77 0.66
Nov-18 0.67 0.66 0.69 0.62
Nov-19 0.69 0.68 0.72 0.66
Nov-20 0.69 0.71 0.73 0.67
Nov-21 0.72 0.73 0.77 0.69
Nov-24 0.75 0.76 0.79 0.74
Nov-25 0.77 0.75 0.79 0.74
Nov-26 0.76 0.80 0.83 0.74
Nov-28 0.80 0.79 0.82 0.77
Dec-1 0.79 0.78 0.79 0.76
Dec-2 0.80 0.76 0.82 0.75
Dec-3 0.78 0.61 0.79 0.58
Dec-4 0.64 0.63 0.66 0.59

GT Biopharma, Inc. Earnings

Data Unavailable

GT Biopharma, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.32 per share, and an increase next year of $0.93 per share.

* GT Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.